CARDINAL HEALTH INC
CAHNYSETrading Snapshot
- Day Range
- $219.02 β $222.79
- 52-Week Range
- $150.78 β $258.30
- Volume
- $2.42B
- Avg Volume
- $2.98B
- Shares Outstanding
- 234.2M
- Next Earnings
- Nov 24, 2026
Fundamentals Snapshot
- Annual Revenue
- $254.25B
- Last Q Revenue
- $63.86B
- P/E Ratio
- 30.4
- P/S Ratio
- 0.2x
- EPS (TTM)
- $7.26
- Dividend Yield
- 0.93%
- Dilution (1yr)
- +0.0%
Why Investors Own CAH
- βHigh-growth profile β revenue up -1.0% YoY with expanding US Equity exposure.
- βHealthy economics β 77% gross margin and 21% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
CARDINAL HEALTH INC
CAHAbout CARDINAL HEALTH INC
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates
At-Home Healthcare Is Growing Fast: Can CAH Ride the Trend?
At-Home Solutions is powering CAH???s growth strategy as investments, acquisitions and technology help it scale in home-based healthcare.

Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade
Cardinal Health (CAH) closed at $220.22 in the latest trading session, marking a -1.08% move from the prior day.

Cardinal Health vs. McKesson: Which Healthcare Stock Is Better?
CAH's specialty-led growth, stronger EPS outlook and improving estimate momentum set up a compelling case against MCK.

Why Cardinal Health (CAH) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

CVS vs. CAH: Which Healthcare Services Stock Is the Better Pick Now?
CVS Health and Cardinal Health are benefiting from healthcare growth, but differences in performance, valuation and targets shape the outlook.

Can CAH's MSO Expansion Unlock Growth in Specialty Care Delivery?
CAH is expanding its MSO strategy across specialty care, with Solaris and broader services aimed at scaling physician networks.